Restoration of immunogenicity to passenger cell-depleted kidney allografts by the addition of donor strain dendritic cells.

PubWeight™: 5.09‹?› | Rank: Top 1%

🔗 View Article (PMC 2186574)

Published in J Exp Med on January 01, 1982

Authors

R I Lechler, J R Batchelor

Articles citing this

(truncated to the top 100)

Cell migration, chimerism, and graft acceptance. Lancet (1992) 12.24

Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo. J Exp Med (2001) 9.70

Cell migration and chimerism after whole-organ transplantation: the basis of graft acceptance. Hepatology (1993) 8.76

Characterization of nonlymphoid cells derived from rat peripheral lymph. J Exp Med (1983) 5.63

Regulation of dendritic cell numbers and maturation by lipopolysaccharide in vivo. J Exp Med (1996) 4.70

Dendritic cells are the principal stimulators of the primary mixed leukocyte reaction in mice. J Exp Med (1983) 4.57

Human dendritic cells. Enrichment and characterization from peripheral blood. J Exp Med (1982) 4.49

Donor cell chimerism permitted by immunosuppressive drugs: a new view of organ transplantation. Immunol Today (1993) 4.29

Cross-presentation by dendritic cells. Nat Rev Immunol (2012) 3.95

Migration of dendritic leukocytes from cardiac allografts into host spleens. A novel pathway for initiation of rejection. J Exp Med (1990) 3.73

Antigen localization and migration in immunity and tolerance. N Engl J Med (1998) 3.71

Small B cells as antigen-presenting cells in the induction of tolerance to soluble protein antigens. J Exp Med (1992) 3.52

Chimerism after liver transplantation for type IV glycogen storage disease and type 1 Gaucher's disease. N Engl J Med (1993) 3.36

Prevention of rejection of murine islet allografts by pretreatment with anti-dendritic cell antibody. Proc Natl Acad Sci U S A (1984) 3.14

Histological analysis of CD11c-DTR/GFP mice after in vivo depletion of dendritic cells. Clin Exp Immunol (2005) 3.12

The lost chord: microchimerism and allograft survival. Immunol Today (1996) 2.81

Hematolymphoid cell trafficking, microchimerism, and GVH reactions after liver, bone marrow, and heart transplantation. Transplant Proc (1993) 2.81

Induction of immune responses in vivo with small numbers of veiled (dendritic) cells. Proc Natl Acad Sci U S A (1983) 2.68

Replication of human immunodeficiency virus type 1 in primary dendritic cell cultures. Proc Natl Acad Sci U S A (1991) 2.25

Lymphoid dendritic cells. Immunology (1987) 2.08

Antigen-pulsed dendritic cells can efficiently induce an antibody response in vivo. J Exp Med (1992) 2.05

Transplantation tolerance from a historical perspective. Nat Rev Immunol (2001) 2.04

Distinct features of dendritic cells and anti-Ig activated B cells as stimulators of the primary mixed leukocyte reaction. J Exp Med (1989) 2.00

Properties of memory T lymphocytes isolated from the mixed leukocyte reaction. Proc Natl Acad Sci U S A (1985) 1.92

Microchimerism, dendritic cell progenitors and transplantation tolerance. Stem Cells (1995) 1.83

Draining lymph nodes of corneal transplant hosts exhibit evidence for donor major histocompatibility complex (MHC) class II-positive dendritic cells derived from MHC class II-negative grafts. J Exp Med (2002) 1.79

Antigen presenting cells in situ: their identification and involvement in immunopathology. Clin Exp Immunol (1983) 1.75

Transplantation tolerance, microchimerism, and the two-way paradigm. Theor Med Bioeth (1998) 1.67

Isolation and characterization of antigen-presenting dendritic cells from the mouse intestinal lamina propria. Immunology (1990) 1.63

Stimulation of mature unprimed CD8+ T cells by semiprofessional antigen-presenting cells in vivo. J Exp Med (1992) 1.61

Immunoelectron microscopic study of the distribution of T cell subsets in rheumatoid synovium. J Exp Med (1983) 1.57

Functional characteristics of the veiled cells in afferent lymph from the rat intestine. Immunology (1986) 1.48

Comparison of topical interleukin-1 vs tumor necrosis factor-alpha blockade with corticosteroid therapy on murine corneal inflammation, neovascularization, and transplant survival (an American Ophthalmological Society thesis). Trans Am Ophthalmol Soc (2007) 1.29

Large mononuclear Ia-positive veiled cells in Peyer's patches. I. Isolation and characterization in rat, guinea-pig and pig. Immunology (1983) 1.20

Large mononuclear Ia-positive veiled cells in Peyer's patches. II. Localization in rat Peyer's patches. Immunology (1983) 1.20

Endothelial cells in allograft rejection. Transplantation (2008) 1.19

Immunological considerations for embryonic and induced pluripotent stem cell banking. Philos Trans R Soc Lond B Biol Sci (2011) 1.17

Isolation, phenotype, and allostimulatory activity of mouse liver dendritic cells. Transplantation (1994) 1.16

Indirect recognition of donor HLA-DR peptides in organ allograft rejection. J Clin Invest (1996) 1.16

The innate immune system in allograft rejection and tolerance. J Immunol (2007) 1.13

Intercellular transfer of MHC and immunological molecules: molecular mechanisms and biological significance. Am J Transplant (2007) 1.06

Immortalized dendritic cell line fully competent in antigen presentation initiates primary T cell responses in vivo. J Exp Med (1993) 1.05

NK cell patrolling and elimination of donor-derived dendritic cells favor indirect alloreactivity. J Immunol (2010) 1.04

Circulating alloreactive T cells correlate with graft function in longstanding renal transplant recipients. J Am Soc Nephrol (2008) 1.04

Pathways of major histocompatibility complex allorecognition. Curr Opin Organ Transplant (2008) 1.02

Influence of dendritic cells on tumor growth. Proc Natl Acad Sci U S A (1985) 1.02

Mechanism of cellular rejection in transplantation. Pediatr Nephrol (2010) 1.01

Immunogenicity of retransplanted rat kidney allografts. Effect of inducing chimerism in the first recipient and quantitative studies on immunosuppression of the second recipient. J Exp Med (1982) 0.99

Role of annexins in endocytosis of antigens in immature human dendritic cells. Immunology (1997) 0.98

Immune recognition and rejection of allogeneic skin grafts. Immunotherapy (2011) 0.97

The role of graft-derived dendritic leukocytes in the rejection of vascularized organ allografts. Recent findings on the migration and function of dendritic leukocytes after transplantation. Ann Surg (1990) 0.96

Rapamycin-treated human endothelial cells preferentially activate allogeneic regulatory T cells. J Clin Invest (2013) 0.96

Immunosuppression for lung transplantation. Front Biosci (Landmark Ed) (2009) 0.95

Survival of deoxyguanosine-treated fetal thymus allografts is prevented by priming with dendritic cells. Immunology (1987) 0.95

The ability of natural tolerance to be applied to allogeneic tissue: determinants and limits. Biol Direct (2007) 0.95

Differential roles of direct and indirect allorecognition pathways in the rejection of skin and corneal transplants. Transplantation (2009) 0.95

Human dendritic cells and transplant outcome. Transplantation (2008) 0.92

Influence of direct and indirect allorecognition pathways on CD4+CD25+ regulatory T-cell function in transplantation. Transpl Int (2007) 0.92

Relevance of regulatory T cell promotion of donor-specific tolerance in solid organ transplantation. Front Immunol (2012) 0.91

Allopeptides and the alloimmune response. Cell Immunol (2007) 0.90

Four-color flow cytometric analysis of peripheral blood donor cell chimerism. Hum Immunol (2003) 0.89

Transplantation tolerance: from theory to clinic. Immunol Rev (2014) 0.88

Origin and biology of the allogeneic response. Cold Spring Harb Perspect Med (2013) 0.87

Divergent role of donor dendritic cells in rejection versus tolerance of allografts. J Am Soc Nephrol (2009) 0.87

Class II antigens on dendritic cells from the synovial fluids of patients with inflammatory arthritis. Clin Exp Immunol (1989) 0.85

Innate immunity and resistance to tolerogenesis in allotransplantation. Front Immunol (2012) 0.85

The direct and indirect allogeneic presentation pathway during acute rejection after human cardiac transplantation. Clin Exp Immunol (2005) 0.85

Antigen location contributes to the pathological features of a transplanted heart graft. Am J Pathol (2004) 0.85

Canine distemper virus: the early blood-brain barrier lesion. Acta Neuropathol (1987) 0.85

Antibody-functionalized peptidic membranes for neutralization of allogeneic skin antigen-presenting cells. Acta Biomater (2014) 0.85

Dendritic cells and innate immunity in kidney transplantation. Kidney Int (2015) 0.84

The effects of renal transplantation on circulating dendritic cells. Clin Exp Immunol (2005) 0.84

Early induction of MHC antigens in human liver grafts. An immunohistologic study. Am J Pathol (1988) 0.83

Contributions of direct and indirect alloresponses to chronic rejection of kidney allografts in nonhuman primates. J Immunol (2011) 0.83

Non-HLA antigens and HLA-DR matching in corneal transplantation. Br J Ophthalmol (1996) 0.83

Selective transplantation. An emerging concept. Ann Surg (1985) 0.82

Rapamycin-conditioned, alloantigen-pulsed myeloid dendritic cells present donor MHC class I/peptide via the semi-direct pathway and inhibit survival of antigen-specific CD8(+) T cells in vitro and in vivo. Transpl Immunol (2011) 0.82

Early passenger leukocyte migration and acute immune reactions in the rat recipient spleen during liver engraftment: with particular emphasis on donor major histocompatibility complex class II+ cells. Transplantation (2002) 0.81

Pancreatic islet transplantation. Induction of graft acceptance by ultraviolet irradiation of donor tissue. Ann Surg (1984) 0.81

Induction of delayed-type hypersensitivity responses to PPD: dendritic cells in synergy with 5-hydroxytryptamine can substitute for macrophages. Immunology (1988) 0.80

Allograft and xenograft acceptance under FK-506 and other immunosuppressant treatment. Ann N Y Acad Sci (1993) 0.79

Donor exosomes rather than passenger leukocytes initiate alloreactive T cell responses after transplantation. Sci Immunol (2016) 0.79

Role of antibodies to self-antigens in chronic allograft rejection: potential mechanism and therapeutic implications. Hum Immunol (2012) 0.78

Kidney-induced cardiac allograft tolerance in miniature swine is dependent on MHC-matching of donor cardiac and renal parenchyma. Am J Transplant (2015) 0.78

Graft-infiltrating host dendritic cells play a key role in organ transplant rejection. Nat Commun (2016) 0.78

Heterogeneity of HLA-DR+ cells in normal human kidney. Immunohistological and cytochemical characterisation of discrete cell populations. J Clin Pathol (1983) 0.78

Relative contribution of direct and indirect allorecognition in developing tolerance after liver transplantation. Liver Transpl (2008) 0.78

Allogeneic beta-islet cells correct diabetes and resist immune rejection. Proc Natl Acad Sci U S A (2002) 0.78

Allorecognition by T Lymphocytes and Allograft Rejection. Front Immunol (2016) 0.77

Immunity and tolerance are related, and governed by antigen migration and localization. Transplant Proc (1999) 0.77

The role of graft-resident Kupffer cells and lymphocytes of donor type during the time course after liver transplantation--a clinico-pathological study. Virchows Arch (2003) 0.77

Ralph Steinman: dendritic cells bring home the Lasker. J Exp Med (2007) 0.77

Differential activation of human T cells to allogeneic endothelial cells, epithelial cells and fibroblasts in vitro. Transplant Res (2012) 0.77

Antigenicity and immunogenicity of allogeneic retinal transplants. J Clin Invest (2001) 0.77

The biology of acute transplant rejection. Ann Surg (1991) 0.77

The indirect alloresponse impairs the induction but not maintenance of tolerance to MHC class I-disparate allografts. Am J Transplant (2009) 0.77

Expression of ICAM-1 (CD54) on normal and leukaemic B cells: implication for the mixed lymphocyte reaction. Clin Exp Immunol (1992) 0.77

Recipient-matching of Passenger Leukocytes Prolongs Survival of Donor Lung Allografts in Miniature Swine. Transplantation (2015) 0.77

The road to transplant tolerance is paved with good dendritic cells. Eur J Immunol (2013) 0.76

The in-vitro inhibition of rat alloantigen presentation by immunotoxins--implications for allografting. Clin Exp Immunol (1989) 0.76

Articles cited by this

A rapid method for the isolation of functional thymus-derived murine lymphocytes. Eur J Immunol (1973) 45.44

Identification of a novel cell type in peripheral lymphoid organs of mice. II. Functional properties in vitro. J Exp Med (1974) 7.58

Graft versus host reactions. Their natural history, and applicability as tools of research. Prog Allergy (1962) 7.11

Dendritic cells: features and functions. Immunol Rev (1980) 6.34

Differential function of major histocompatibility complex antigens in T-lymphocyte activation. Nature (1976) 3.87

Rat dendritic cells function as accessory cells and control the production of a soluble factor required for mitogenic responses of T lymphocytes. Proc Natl Acad Sci U S A (1980) 3.42

The traditional and a new version of the mouse H-2 complex. Nature (1981) 3.12

Immunological enhancement of rat kidney grafts. Lancet (1969) 2.73

Monoclonal antibodies to Ia antigens from rat thymus: cross reactions with mouse and human and use in purification of rat Ia glycoproteins. Immunol Rev (1979) 2.17

Failure of long surviving, passively enhanced kidney allografts to provoke T-dependent alloimmunity. I. Retransplantation of (AS X AUG)F1 kidneys into secondary AS recipients. J Exp Med (1979) 1.88

Role of macrophages in the generation of T helper cells. IV. Nature of genetically related factor derived from macrophages incubated with soluble antigens. Eur J Immunol (1976) 1.57

Major histocompatibility complex antigens in rat kidney, ureter, and bladder. Localization with monoclonal antibodies and demonstration of Ia-positive dendritic cells. Transplantation (1981) 1.55

The immune response to allogeneic rat platelets; Ag-B antigens in matrix form lacking Ia. Eur J Immunol (1977) 1.42

RtH-1 antigens in 39 rat strains and six congenic lines. Transplant Proc (1971) 1.40

Mechanism of antigen binding by T cells. H-2(I-A)-restricted binding of antigen plus Ia by helper cells. Eur J Immunol (1980) 1.37

Allogeneic stimulation modulates the in vitro response of T cells to transplantation antigen. Nature (1974) 1.37

Cellular and humoral immunity after allogeneic renal transplantation in the rat. V. Appearance of anti-idiotypic antibody and its relationship to cellular immunity after treatment with donor spleen cells and alloantibody. Transplantation (1976) 1.27

The uptake of 125I-labeled rat alloantibody and its loss after combination with antigen. Transplantation (1973) 1.23

Articles by these authors

Leptin modulates the T-cell immune response and reverses starvation-induced immunosuppression. Nature (1998) 7.36

Genetic basis of rheumatoid disease: HLA antigens, disease manifestations, and toxic reactions to drugs. Br Med J (1978) 4.29

Human CD4(+)CD25(+) cells: a naturally occurring population of regulatory T cells. Blood (2001) 3.66

The role of T helper 17 (Th17) and regulatory T cells (Treg) in human organ transplantation and autoimmune disease. Clin Exp Immunol (2007) 3.51

Immune response-associated production of neopterin. Release from macrophages primarily under control of interferon-gamma. J Exp Med (1984) 3.31

Splicing by overlap extension by PCR using asymmetric amplification: an improved technique for the generation of hybrid proteins of immunological interest. Gene (1997) 3.28

Family study of the major histocompatibility complex in patients with systemic lupus erythematosus: importance of null alleles of C4A and C4B in determining disease susceptibility. Br Med J (Clin Res Ed) (1983) 2.86

Immunological enhancement of rat kidney grafts. Lancet (1969) 2.73

Statement on the nomenclature of human C4 allotypes. Immunobiology (1983) 2.66

Hydralazine-induced systemic lupus erythematosus: influence of HLA-DR and sex on susceptibility. Lancet (1980) 2.63

HLA-DR antigens and toxic reaction to sodium aurothiomalate and D-penicillamine in patients with rheumatoid arthritis. N Engl J Med (1980) 2.52

Leptin protects mice from starvation-induced lymphoid atrophy and increases thymic cellularity in ob/ob mice. J Clin Invest (1999) 2.48

Structural model of HLA-DR1 restricted T cell antigen recognition. Cell (1988) 2.41

Clinical, pathological, HLA antigen and immunological evidence for disease heterogeneity in myasthenia gravis. Brain (1980) 2.36

Requirement for leptin in the induction and progression of autoimmune encephalomyelitis. J Immunol (2001) 2.20

Factors influencing the risk of multiple sclerosis developing in patients with optic neuritis. Brain (1978) 2.19

"Exon-shuffling" maps control of antibody- and T-cell-recognition sites to the NH2-terminal domain of the class II major histocompatibility polypeptide A beta. Proc Natl Acad Sci U S A (1985) 1.93

Histocompatibility antigens, autoantibodies, and immunoglobulins in alcoholic liver disease. Br Med J (1976) 1.91

Enhanced antibody responses in active chronic hepatitis: relation to HLA-B8 and HLA-B12 and porto-systemic shunting. Lancet (1976) 1.89

Failure of long surviving, passively enhanced kidney allografts to provoke T-dependent alloimmunity. I. Retransplantation of (AS X AUG)F1 kidneys into secondary AS recipients. J Exp Med (1979) 1.88

HLA and hepatitis B infection. Lancet (1994) 1.85

Isolation of endothelial cells from murine tissue. J Immunol Methods (2000) 1.81

Assessment of the contribution that direct allorecognition makes to the progression of chronic cardiac transplant rejection in humans. Circulation (1998) 1.79

Increased leptin levels in serum and peritoneal fluid of patients with pelvic endometriosis. J Clin Endocrinol Metab (2000) 1.75

B-lymphocyte alloantigens associated with multiple sclerosis. Lancet (1976) 1.73

The significance of the association between HLA and multiple sclerosis. Br Med Bull (1978) 1.65

Histocompatibility antigens in diabetic identical twins. Lancet (1975) 1.59

The molecular basis of alloreactivity. Immunol Today (1990) 1.56

Retinal venous sheathing in optic neuritis. Its significance for the pathogenesis of multiple sclerosis. Brain (1987) 1.54

Influence of defined incompatibilities and area of burn on skin-homograft survival in burned-subjects. Lancet (1969) 1.52

Nitric oxide-mediated expression of Bcl-2 and Bcl-xl and protection from tumor necrosis factor-alpha-mediated apoptosis in porcine endothelial cells after exposure to low concentrations of xenoreactive natural antibody. Transplantation (2001) 1.46

Thy-1+ dendritic epidermal cells belong to the T-cell lineage. Proc Natl Acad Sci U S A (1987) 1.46

HLA matching and corneal grafting. Lancet (1976) 1.46

Histocompatibility antigens in active chronic hepatitis and primary biliary cirrhosis. Br Med J (1974) 1.45

Loss of direct and maintenance of indirect alloresponses in renal allograft recipients: implications for the pathogenesis of chronic allograft nephropathy. J Immunol (2001) 1.43

Speculations on the specificity of suppression. Immunol Today (1989) 1.43

Peptide analogues as a strategy to induce tolerance in T cells with indirect allospecificity. Transplantation (2000) 1.43

The immune response to allogeneic rat platelets; Ag-B antigens in matrix form lacking Ia. Eur J Immunol (1977) 1.42

Postinjury vascular intimal hyperplasia in mice is completely inhibited by CD34+ bone marrow-derived progenitor cells expressing membrane-tethered anticoagulant fusion proteins. J Thromb Haemost (2006) 1.41

The influence of sex upon the antibody response to an incompatible tumour. Immunology (1965) 1.38

Translational mini-review series on Th17 cells: induction of interleukin-17 production by regulatory T cells. Clin Exp Immunol (2009) 1.37

A reassessment of the risk of multiple sclerosis developing in patients with optic neuritis after extended follow-up. J Neurol Neurosurg Psychiatry (1987) 1.35

Phytohaemagglutinin transformation of lymphocytes in burned patients. Transplantation (1971) 1.32

Transformation of lymphocytes from patients awaiting cadaver renal transplants. Lancet (1976) 1.32

MRL/Mp CD4+,CD25- T cells show reduced sensitivity to suppression by CD4+,CD25+ regulatory T cells in vitro: a novel defect of T cell regulation in systemic lupus erythematosus. Arthritis Rheum (2005) 1.32

Allorecognition. Am J Transplant (2001) 1.30

HLA-DRw4 and rheumatoid arthritis. Lancet (1979) 1.29

Matching for HLA in transplantation. Br Med Bull (1978) 1.27

Enhancement of renal allografts in rats and man. Transplant Rev (1972) 1.27

Qualitative and quantitative studies of antigen-presenting cell function by using I-A-expressing L cells. J Immunol (1985) 1.26

An immunogenetic basis for the tissue involvement in Behçet's syndrome. Immunology (1979) 1.25

Strong association between HLA-DRW2 and antibody-mediated Goodpasture's syndrome. Lancet (1978) 1.23

The uptake of 125I-labeled rat alloantibody and its loss after combination with antigen. Transplantation (1973) 1.23

Influence of HL-A incompatibility on cadaveric renal transplantation. Lancet (1969) 1.21

Are primary alloresponses truly primary? Int Immunol (1990) 1.21

Leptin potentiates experimental autoimmune encephalomyelitis in SJL female mice and confers susceptibility to males. Eur J Immunol (2001) 1.21

The maintenance of human CD4+ CD25+ regulatory T cell function: IL-2, IL-4, IL-7 and IL-15 preserve optimal suppressive potency in vitro. Int Immunol (2007) 1.20

Transplantation antigens from human spleens. Nature (1968) 1.20

Expression of indoleamine 2,3-dioxygenase (IDO) by endothelial cells: implications for the control of alloresponses. Am J Transplant (2006) 1.19

Donor-specific indirect pathway analysis reveals a B-cell-independent signature which reflects outcomes in kidney transplant recipients. Am J Transplant (2011) 1.18

Rosette inhibition test in severely burned patients. Br Med J (1973) 1.17

Early genetic events in T cell development analyzed by in situ hybridization. J Exp Med (1987) 1.16

Differential expression of CTLA-4 among T cell subsets. Clin Exp Immunol (2004) 1.15

Viral infection in patients with multiple sclerosis and HLA-DR matched controls. Brain (1986) 1.15

HLA antigen frequencies in systemic vasculitis: increase in HLA-DR2 in Wegener's granulomatosis. Arthritis Rheum (1983) 1.15

Clinical grade manufacturing of human alloantigen-reactive regulatory T cells for use in transplantation. Am J Transplant (2013) 1.14

Significant frequencies of T cells with indirect anti-donor specificity in heart graft recipients with chronic rejection. Circulation (2000) 1.14

Immunological enchancement of human kidney graft. Lancet (1970) 1.12

Plasma exchange and immunosuppression in the stiff man syndrome. Lancet (1989) 1.12

Linkage of Chido and HL-A. Tissue Antigens (1974) 1.12

The arthropathy of cystic fibrosis. Ann Rheum Dis (1988) 1.10

Antigen recognition influences transendothelial migration of CD4+ T cells. J Immunol (1999) 1.10

Histocompatible unrelated volunteer donors compared with HLA nonidentical family donors in marrow transplantation for aplastic anemia and leukemia. Blood (1986) 1.09

Histocompatibility antigens as markers of abnormal iron metabolism in patients with idiopathic haemochromatosis and their relatives. Lancet (1977) 1.09

Double-blind controlled trial of immunosuppression in the treatment of multiple sclerosis: final report. Lancet (1982) 1.09

Marrow transplantation for patients in the chronic phase of chronic granulocytic leukaemia. Lancet (1982) 1.08

The use of enhancement in studying tumor antigens. Cancer Res (1968) 1.07

SLE: a rheumatological view. Analysis of the clinical features, serology and immunogenetics of 100 SLE patients during long-term follow-up. Q J Med (1990) 1.06

Selective suppression of cellular immunity by antilymphocyte serum. Transplantation (1968) 1.06

Multiple sclerosis and HLA DQw1. Lancet (1986) 1.06

Adult onset immunodeficiency caused by inherited adenosine deaminase deficiency. J Immunol (1994) 1.06

Intercellular transfer of MHC and immunological molecules: molecular mechanisms and biological significance. Am J Transplant (2007) 1.06

Indium-111 labelled lymphocytes: isotope distribution and cell division. Eur J Nucl Med (1997) 1.06

Allorecognition of DR1 by T cells from a DR4/DRw13 responder mimics self-restricted recognition of endogenous peptides. Proc Natl Acad Sci U S A (1989) 1.05

Allorecognition and the alloresponse: clinical implications. Tissue Antigens (2007) 1.05

The Rosette inhibition test in skin-grafted patients. Br Med J (1974) 1.05

I-A-restricted T cell antigen recognition. Analysis of the roles of A alpha and A beta using DNA-mediated gene transfer. J Exp Med (1986) 1.05

Allogeneic bone marrow transplantation for chronic myeloid leukemia using sibling and volunteer unrelated donors. A comparison of complications in the first 2 years. Ann Intern Med (1993) 1.04

Antigen presentation by parenchymal cells: a route to peripheral tolerance? Immunol Rev (1999) 1.04

HLA antigens in recurrent oral ulceration. Arch Dermatol (1977) 1.04

Prediction of graft versus host disease by frequency analysis of cytotoxic T cells after unrelated donor bone marrow transplantation. Transplantation (1989) 1.03

HL-A matching in treatment of burned patients with skin allografts. Lancet (1970) 1.02

The immunogenetics of SLE. Clin Rheum Dis (1982) 1.02

Recovery after optic neuritis in childhood. J Neurol Neurosurg Psychiatry (1988) 1.01

HLA antigens in Guillain-Barré syndrome. Lancet (1977) 1.00

Porcine CTLA4-Ig lacks a MYPPPY motif, binds inefficiently to human B7 and specifically suppresses human CD4+ T cell responses costimulated by pig but not human B7. J Immunol (2000) 1.00

Transplant accommodation in highly sensitized patients: a potential role for Bcl-xL and alloantibody. Am J Transplant (2001) 1.00